Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals

Clin Gastroenterol Hepatol. 2017 Apr;15(4):605. doi: 10.1016/j.cgh.2016.11.030. Epub 2016 Dec 3.

Authors

Resat Ozaras¹, Bilgul Mete¹, Fehmi Tabak¹

Affiliation

¹ Infectious Diseases Department, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.

PMID: 27923721
DOI: 10.1016/j.cgh.2016.11.030

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents
Hepacivirus
Hepatitis B virus*
Hepatitis B*
Hepatitis C
Humans

Substances

Antiviral Agents